Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis von Thanaraj, S., Hamlin, P. J., Ford, A. C.

Volltext

Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease von Derwa, Y., Gracie, D. J., Hamlin, P. J., Ford, A. C.

Volltext

Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience von Suares, N. C., Hamlin, P. J., Greer, D. P., Warren, L., Clark, T., Ford, A. C.

Volltext

Costs of care for Crohn’s disease following the introduction of infliximab: a single‐centre UK experience von Sprakes, M. B., Ford, A. C., Suares, N. C., Warren, L., Greer, D., Donnellan, C. F., Jennings, J. S. R., Everett, S. M., Hamlin, P. J.

Volltext

Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse von Burgoyne, C H, Field, S L, Brown, A K, Hensor, E M, English, A, Bingham, S L, Verburg, R, Fearon, U, Lawson, C A, Hamlin, P J, Straszynski, L, Veale, D, Conaghan, P, Hull, M A, van Laar, J M, Tennant, A, Emery, P, Isaacs, J D, Ponchel, F

Volltext

The relationship between different information sources and disease‐related patient knowledge and anxiety in patients with inflammatory bowel disease von Selinger, C. P., Carbery, I., Warren, V., Rehman, A. F., Williams, C. J., Mumtaz, S., Bholah, H., Sood, R., Gracie, D. J., Hamlin, P. J., Ford, A. C.

Volltext

Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission von Brooks, A.J., Sebastian, S., Cross, S.S., Robinson, K., Warren, L., Wright, A., Marsh, A.M., Tsai, H., Majeed, F., McAlindon, M.E., Preston, C., Hamlin, P.J., Lobo, A.J.

Volltext

Editorial: probiotics in inflammatory bowel disease—wrong organisms, wrong disease, or flawed concepts? Authors’ reply von Gracie, D. J., Derwa, Y., Hamlin, P. J., Ford, A. C.

Volltext

Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature von Hamlin, P J, Shah, M N, Scott, N, Wyatt, J I, Howdle, P D

Volltext

Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis von Halpin, S., Hamlin, P. J.

Volltext

Commentary: salvage medical therapy for acute severe colitis – ciclosporin or infliximab? von Sprakes, M. B., Hamlin, P. J.

Volltext

Anti-TNF associated psoriasis von Hamlin, P. J., Goodfield, M.

Volltext

Infliximab and surgical treatment of complex anal Crohn's disease von Duff, S., Sagar, P. M., Rao, M., Dolling, S., Sprakes, M., Hamlin, P. J.

Volltext

Commentary: infliximab or adalimumab in Crohn's disease? von Sprakes, M. B., Hamlin, P. J.

Volltext

Is propionyl-l-carnitine therapy effective in ulcerative colitis? von Turner, L. V. B., Hamlin, P. J.

Volltext

Autoimmune hepatitis triggered by hepatitis A von Singh, G, Palaniappan, S, Rotimi, O, Hamlin, P J

Volltext

Effect of oral zinc in hepatic encephalopathy remains unclear von Coughlan, J., Hamlin, P. J., Ford, A. C.

Volltext

No Polymorphism in the Tissue Transglutaminase Gene Detected in Coeliac Disease Patients von ALDERSLEY, M. A, HAMLIN, P. J, JONES, P. F, MARKHAM, A. F, ROBINSON, P. A, HOWDLE, P. D

Volltext

Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates von Halpin, S. J., Hamlin, P. J., Ford, A. C.

Volltext

Predictors of response and loss of response to infliximab therapy for crohn's disease: a large UK single centre experience von Sprakes, M, Ford, A C, Warren, L, Greer, D, Hamlin, P J

Volltext